Putnam Investments’s Kindred Biosciences, Inc. KIN Stock Holding History

Putnam Investments’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-149,500	Closed	-$508K	–	1477
2015 Q4	$508K	Hold	149,500	–	–	﹤0.01%	1311
2015 Q3	$777K	Hold	149,500	–	–	﹤0.01%	1230
2015 Q2	$1.02M	Hold	149,500	–	–	﹤0.01%	1220
2015 Q1	$1.07M	Hold	149,500	–	–	﹤0.01%	1189
2014 Q4	$1.11M	Hold	149,500	–	–	﹤0.01%	1163
2014 Q3	$1.38M	Sell	149,500 -900	-0.6%	-$12.2K	﹤0.01%	1133
2014 Q2	$2.8M	Hold	150,400	–	–	0.01%	946
2014 Q1	$2.79M	Buy	150,400 +400	+0.3%	+$7.63K	0.01%	977
2013 Q4	$1.67M	Buy	+150,000	New	+$1.79M	﹤0.01%	1088

Other funds holding KIN

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Putnam Investments's KIN Position: Q1 2016 in Review

Putnam Investments sold out of Kindred Biosciences, Inc. (KIN) in Q1 2016, closing a stake of 149,500 shares — an estimated $508K sold.

Putnam Investments first reported a position in KIN in Q4 2013 and held it in 9 quarters. The position peaked at $2.8M in Q2 2014. 44 funds tracked by Wall St. Rank hold KIN as of Q1 2016.

Putnam Investments reported no remaining Kindred Biosciences, Inc. position as of Q1 2016 after selling out during the quarter.
Putnam Investments sold 149,500 Kindred Biosciences, Inc. shares in Q1 2016, an estimated $508K.
Putnam Investments first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 9 quarters.
Putnam Investments's Kindred Biosciences, Inc. position peaked at $2.8M in Q2 2014.
44 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2016.

Based on Putnam Investments's 13F filing for Q1 2016, filed 16 May 2016.